Hepatology News

From 2002 to 2021, the incidence rate of alcohol-associated hepatitis “more than doubled” among adolescents and young adults in Ontario, Canada, with the highest uptick observed among females, according to research in JAMA Network Open.

Midlife women with a metabolic dysfunction-associated steatotic liver disease diagnosis were more likely to report severe or very severe hot flashes, though researchers found no direct link between the two conditions, data show.

As physicians, we have all borne witness to patients dying at a young age, whether from an unforeseen illness or injury.

The noncompete ban issued by the Federal Trade Commission emerged as one of the most talked about employment law issues in 2024 affecting workers, including medical professionals.

Healio spoke with an expert about the importance of social media, why physicians should utilize it and the do’s and don’ts behind this growing form of communication.

Endoscopic sleeve gastroplasty with lifestyle intervention was more effective than lifestyle changes alone in achieving weight loss and histological improvement in patients with metabolic dysfunction-associated steatohepatitis and obesity.

Health equity has become a buzzword in medical institutions and health care organizations, especially when it comes to rural communities. But too often, the conversations don't move past the talking stage.

The FDA has granted Cour Pharmaceuticals orphan drug designation for CNP-104, a biodegradable nanoparticle in development for the treatment of primary biliary cholangitis, the company announced in a press release.

Hispanic patients hospitalized for alcohol use disorder were more likely to develop alcohol-associated hepatitis, decompensated cirrhosis and related complications compared with non-Hispanic white patients, according to published data.